Mary Prenon

Mary Prenon

Freelance Reporter
Mary T. Prenon covers real estate and business. She has been a writer and reporter for over 25 years with various print and broadcast media in New York.

LATEST

Abbott Laboratories Issues Correction on 3 Million Glucose Sensors Over Possible Faulty Readings

Abbott Laboratories Issues Correction on 3 Million Glucose Sensors Over Possible Faulty Readings

More Than Half of Americans Weigh Hosting Thanksgiving in Home Search, Survey Finds

More Than Half of Americans Weigh Hosting Thanksgiving in Home Search, Survey Finds

Small Retailers Enter Holiday Season Optimistic

Small Retailers Enter Holiday Season Optimistic

Ford Now Offering Used Vehicles on Amazon

Ford Now Offering Used Vehicles on Amazon

NAR Projects US Home Sales to Jump by 14 Percent in 2026

NAR Projects US Home Sales to Jump by 14 Percent in 2026

US Homebuilders Offer ‘Elevated’ Incentives Amid Affordability Challenges

US Homebuilders Offer ‘Elevated’ Incentives Amid Affordability Challenges

Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal to Boost Flu Prevention

Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal to Boost Flu Prevention

Abbott Laboratories Issues Correction on 3 Million Glucose Sensors Over Possible Faulty Readings

Abbott Laboratories Issues Correction on 3 Million Glucose Sensors Over Possible Faulty Readings

More Than Half of Americans Weigh Hosting Thanksgiving in Home Search, Survey Finds

More Than Half of Americans Weigh Hosting Thanksgiving in Home Search, Survey Finds

Small Retailers Enter Holiday Season Optimistic

Small Retailers Enter Holiday Season Optimistic

Ford Now Offering Used Vehicles on Amazon

Ford Now Offering Used Vehicles on Amazon

NAR Projects US Home Sales to Jump by 14 Percent in 2026

NAR Projects US Home Sales to Jump by 14 Percent in 2026

US Homebuilders Offer ‘Elevated’ Incentives Amid Affordability Challenges

US Homebuilders Offer ‘Elevated’ Incentives Amid Affordability Challenges

Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal to Boost Flu Prevention

Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal to Boost Flu Prevention